Gastrointestinal Gene Therapy Biotech DNAlite Therapeutics Raises $1.5M in Seed Funding

Gastrointestinal Gene Therapy Biotech DNAlite Therapeutics Raises $1.5M in Seed Funding


Aug 8, 2018--DNAlite Therapeutics, Inc., an early stage preclinical therapeutic company has raised $1.5 million in a seed-stage financing. DNAlite was founded by UC Berkeley graduates Mubhij Ahmad and Timothy Day in 2016.



from Biotech News